Skip to main content
SpringerLink
Log in

Role of Growth Factors and Biological Response Modifiers in Lung, Head and Neck and Gastrointestinal Tumors

  • Chapter
Modification of Radiation Response

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 141 Accesses

Abstract

The role of growth factors in tumor growth and progression and their usefulness as prognostic and/or predictive factors is a topic of great interest which is reflected by an increasing number of publications over the last few years. These data are briefly summarized in this chapter for a variety of tumors, followed by a discussion of therapeutic approaches that are not covered elsewhere in this book.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aebersold DM, Froehlich SC, Jonczy M et al (2002) Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiother Oncol 63:275–283

    Article  PubMed  CAS  Google Scholar 

  • Anderson H, Gurney H, Thatcher N et al (1991) Recombinant human GM-CSF in small cell lung cancer: a phase I/II study. Rec Res Cancer Res 121:155–161

    Article  CAS  Google Scholar 

  • Antman KS, Griffin JD, Elias A et al (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593–598

    Article  PubMed  CAS  Google Scholar 

  • Arnaout AH, Dawson PM, Soomro S et al (1992) HER2 (c-erbB-2) oncoprotein expression in colorectal adeno-carcinoma: an immunohistochemical study using three different antibodies. J Clin Pathol 45:726–727

    Article  PubMed  CAS  Google Scholar 

  • Bennett WP, el-Deiry WS, Rush WL et al (1998) p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer. Clin Cancer Res 4:1499–1506

    PubMed  CAS  Google Scholar 

  • Bitran JD, Green M, Perry M et al (1995) A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGB. Am J Clin Oncol 18:67–70

    Article  CAS  Google Scholar 

  • Bradley JD, Scott CB, Paris KJ et al (2002) A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04). Int J Radiat Oncol Biol Phys 52:1173–1179

    Article  PubMed  CAS  Google Scholar 

  • Brattstrom D, Bergqvist M, Hesselius P et al (2002) Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumors and poorer survival in non-small cell lung cancer patients. Lung Cancer 37:57–63

    Article  PubMed  Google Scholar 

  • Brien TP, Odze RD, Sheehan CE et al (2000) HER-2/neu gene amplification by FISH predicts poor survival in Barrett’s esophagus-associated adenocarcinoma. Hum Pathol 31: 35–39

    Article  PubMed  CAS  Google Scholar 

  • Bronchud MH, Scarffe JH, Thatcher N et al (1987) Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56:809–813

    Article  PubMed  CAS  Google Scholar 

  • Cascinu S, Graziano F, Catalano V et al (2002) An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Br J Cancer 86:744–749

    Article  PubMed  CAS  Google Scholar 

  • Crawford J, Ozer H, Stoller R et al (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164–170

    Article  PubMed  CAS  Google Scholar 

  • De Vita F, Orditura M, Auriemma A et al (1998) Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer. Oncol Rep 5:649–652

    PubMed  Google Scholar 

  • De Vita F, Orditura M, Galizia G et al (2000) Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 117:365–373

    Article  PubMed  Google Scholar 

  • Di Carlo A, Mariano A, D'Alessandro V et al (2001) Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias. Oncol Rep 8:387–392

    Google Scholar 

  • Fontanini G, Faviana P, Lucchi M et al (2001) A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinomas. Br J Cancer 86: 558–563

    Article  Google Scholar 

  • Friess H, Wang L, Zhu Z et al (1999) Growth factor receptors are differentially expressed in cancers of the papilla of Vater and pancreas. Ann Surg 230:767–774

    Article  PubMed  CAS  Google Scholar 

  • Gallo O, Masini E, Bianchi B et al (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33: 708–714

    Article  PubMed  CAS  Google Scholar 

  • Ghaemmaghami M, Jett JR (1998) New agents in the treatment of small cell lung cancer. Chest 113:86S–91S

    Article  PubMed  CAS  Google Scholar 

  • Gochi A, Orita K, Fuchimoto S et al (2001) The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients. Br J Cancer 84:443–451

    Article  PubMed  CAS  Google Scholar 

  • Gunther K, Dworak O, Remke S et al (2002) Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103:68–78

    Article  PubMed  Google Scholar 

  • Gupta AK, McKenna WG, Weber CN (2002) Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 8:885–892

    PubMed  Google Scholar 

  • Han H, Landreneau RJ, Santucci TS et al (2002) Prognostic value of immunohistochemical expression of p53, HER-2/ neu, and bcl-2 in stage I non-small cell lung cancer. Hum Pathol 33:105–110

    Article  PubMed  CAS  Google Scholar 

  • Harari PM, Huang SM (2002) Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development. Semin Radiat Oncol 12:21–26

    Article  PubMed  Google Scholar 

  • Henke M, Guttenberger R, Barke A et al (1999) Erythropoietin for patients undergoing radiotherapy: a pilot study. Radiother Oncol 50:185–190

    Article  PubMed  CAS  Google Scholar 

  • Homer JJ, Greenman J, Stafford ND (2001) The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer: relationship with radioresistance. Clin Otolaryngol 26:498–504

    Article  PubMed  CAS  Google Scholar 

  • Huang SM, Bock JM, Harari PM (1999) Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 59:1935–1940

    PubMed  CAS  Google Scholar 

  • Imdahl A, Bognar G, Schulte-Monting J et al (2002) Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer. Eur J Cardiothorac Surg 21: 657–663

    Article  PubMed  CAS  Google Scholar 

  • Ito H, Oshita F, Kameda Y et al (2002) Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas. Oncol Rep 9:119–123

    PubMed  CAS  Google Scholar 

  • Jett JR, Maksymiuk AW, Su JQet al (1994) Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer. J Clin Oncol 12:2321–2326

    PubMed  CAS  Google Scholar 

  • Joensuu H, Anttonen A, Eriksson M et al (2002) Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 62: 5210–5217

    PubMed  CAS  Google Scholar 

  • Junker K (2001) Prognostic factors in stage I/II non-small cell lung cancer. Lung Cancer 33[Suppl 1]:S17–S24

    Article  PubMed  Google Scholar 

  • Karayiannakis AJ, Syrigos KN, Polychronidis A et al (2002) Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 236:37–42

    Article  PubMed  Google Scholar 

  • Kelly K, Crowley JJ, Bunn PA Jr et al (1995) Role of recombinant interferon alfa-2a maintenance in patients with limitedstage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study. J Clin Oncol 13:2924–2930

    PubMed  CAS  Google Scholar 

  • Khan AJ, King BL, Smith BD et al (2002) Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 8:540–548

    PubMed  CAS  Google Scholar 

  • Knoll MR, Rudnitzki D, Sturm J et al (2001) Correlation of postoperative survival and angiogenic growth factors in pancreatic carcinoma. Hepatogastroenterology 48: 1162–1165

    PubMed  CAS  Google Scholar 

  • Kristensen CA, Jensen PB, Poulsen HS et al (1996) Small cell lung cancer: biological and therapeutic aspects. Crit Rev Oncol Hematol 22:27–60

    Article  PubMed  CAS  Google Scholar 

  • Laack E, Kohler A, Kugler C et al (2002) Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small cell lung cancer. Ann Oncol 13:1550–1557

    Article  PubMed  CAS  Google Scholar 

  • Landriscina M, Cassano A, Ratto C et al (1998) Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 78:765–770

    Article  PubMed  CAS  Google Scholar 

  • Lee DY, Kim SJ, Lee YC (1999) Serum insulin-like growth factor (IGF)-1 and IGF-binding proteins in lung cancer patients. J Korean Med Sci 14:401–404

    PubMed  CAS  Google Scholar 

  • Lennard CM, Patel A, Wilson J et al (2001) Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 129:552–558

    Article  PubMed  CAS  Google Scholar 

  • Liu DH, Zhang XY, Fan DM et al (2001) Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma. World J Gastroenterol 7: 500–505

    PubMed  CAS  Google Scholar 

  • Mall JW, Schwenk W, Philipp AW et al (2002) Serum vascular endothelial growth factor levels correlate better with tumor stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase. Respirology 7: 99–102

    Article  PubMed  Google Scholar 

  • Masuda N, Fukuoka M, Furuse K (1992) CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer. Oncology 49[Suppl 1]: 19–24

    Article  PubMed  Google Scholar 

  • Mattson K, Niiranen A, Pyrhonen S et al (1992) Natural interferon alfa as maintenance therapy for small cell lung cancer. Eur J Cancer 28A:1387–1391

    Article  PubMed  CAS  Google Scholar 

  • Maurizi M, Almadori G, Ferrandina G et al (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74: 1253–1257

    Article  PubMed  CAS  Google Scholar 

  • Minami K, Saito Y, Imamura H et al (2002) Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinomas of the lung. Lung Cancer 38:51–55

    Article  PubMed  Google Scholar 

  • Mineta H, Miura K, Ogino T et al (2002) Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22:1039–1044

    PubMed  CAS  Google Scholar 

  • Mouritzen C (1990) Bestatin as adjuvant treatment in operated stage I and stage II non-small cell lung cancer. European Lung Cancer Study Group. Acta Oncol 29:817–820

    Article  PubMed  CAS  Google Scholar 

  • Mukai M, Morita S, Tsunemoto H (1992) Combination therapy of local administration of OK-432 and radiation for esophageal cancer. Int J Radiat Oncol Biol Phys 22:1047–1050

    Article  PubMed  CAS  Google Scholar 

  • Nakayama Y, Sato T, Shibao K et al (2002) Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Anticancer Res 22:2437–2442

    PubMed  Google Scholar 

  • Nieder C, Petersen S, Petersen C et al (2001) The challenge of p53 as prognostic and predictive factor in Hodgkin’s or non-Hodgkin’s lymphoma. Ann Hematol 80:2–8

    Article  PubMed  CAS  Google Scholar 

  • Niedergethmann M, Hildenbrand R, Wostbrock B et al (2002) High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 25:122–129

    Article  PubMed  Google Scholar 

  • O’Byrne KJ, Cox G, Swinson D et al (2001) Towards a biological staging model for operable non-small cell lung cancer. Lung Cancer 34[Suppl 2]:S83–S89

    Article  PubMed  Google Scholar 

  • Paccagnella A, Favaretto A, Riccardi A et al (1993) Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics. Cancer 72: 697–706

    Article  PubMed  CAS  Google Scholar 

  • Piyathilake CJ, Frost AR, Manne U et al (2002) Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 8: 734–744

    PubMed  CAS  Google Scholar 

  • Potti A, Willardson J, Forseen C et al (2002) Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung cancer. Lung Cancer 36:257–261

    Article  PubMed  Google Scholar 

  • Raben D, Helfrich BA, Chan D et al (2002) ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol 29:37–46

    Article  PubMed  CAS  Google Scholar 

  • Robert F, Ezekiel MP, Spencer SA et al (2001) Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 19: 3234–3243

    PubMed  CAS  Google Scholar 

  • Safran H, Steinhoff M, Mangray S et al (2001) Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. Am J Clin Oncol 24:496–499

    Article  PubMed  CAS  Google Scholar 

  • Sartor CI (2000) Biological modifiers as potential radiosen-sitizers: targeting the epidermal growth factor receptor family. Semin Oncol 27:15–20

    PubMed  CAS  Google Scholar 

  • Scagliotti GV, Novello S (2001) Role of erythropoietin in the treatment of lung cancer associated anaemia. Lung Cancer 34[Suppl 4]:S91–S94

    Article  PubMed  Google Scholar 

  • Selvaggi G, Scagliotti GV, Torri V et al (2002) HER-2/neu overexpression in patients with radically resected non-small cell lung carcinoma. Impact on long-term survival. Cancer 94:2669–2674

    Article  PubMed  Google Scholar 

  • Seo Y, Baba H, Fukuda T et al (2000) High expression of vascular endothelial growth factor is associated with liver metastases and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 88:2239–2245

    Article  PubMed  CAS  Google Scholar 

  • Shimada H, Takeda A, Nabeya Y et al (2001) Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer 92:663–669

    Article  PubMed  CAS  Google Scholar 

  • Shimada H, Hoshino T, Okazumi S et al (2002) Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. Br J Cancer 86:552–557

    Article  PubMed  CAS  Google Scholar 

  • Shou Y, Hirano T, Gong Y et al (2001) Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small cell lung cancer. Br J Cancer 85: 1706–1712

    Article  PubMed  CAS  Google Scholar 

  • Takada M, Fukuoka M, Negoro S et al (1990) Combination therapy with bestatin in inoperable lung cancer. A randomized trial. Acta Oncol 29:821–825

    Article  PubMed  CAS  Google Scholar 

  • Takahama M, Tsutsumi M, Tsujiuchi T et al (1998) Frequent expression of the vascular endothelial growth factor in human non-small cell lung cancers. Jpn J Clin Oncol 28: 176–181

    Article  PubMed  CAS  Google Scholar 

  • Thames HD, Petersen C, Petersen S et al (2002) Immunohisto-chemically detected p53 mutations in epithelial tumors and results of treatment with chemotherapy and radiotherapy. A treatment-specific overview of the clinical data. Strahlenther Onkol 178:411–421

    Article  PubMed  Google Scholar 

  • Umezawa H, Aoyagi T, Suda H et al (1976) Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo) 29:97–99

    Article  CAS  Google Scholar 

  • Volm M, Koomägi R, Mattern J (1999) PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. Anticancer Res 19:651–656

    PubMed  CAS  Google Scholar 

  • Wanebo HJ, Jun MY, Strong EW et al (1975) T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 130:445–451

    Article  PubMed  CAS  Google Scholar 

  • Wang LS, Chow KC, Chi KH et al (1999) Prognosis of esophageal squamous cell carcinoma: analysis of clinicopatho-logical and biological factors. Am J Gastroenterol 94: 1933–1940

    Article  PubMed  CAS  Google Scholar 

  • Werther K, Christensen IJ, Brunner N et al (2000) Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. Eur J Surg Oncol 26:657–662

    Article  PubMed  CAS  Google Scholar 

  • Wu Y, Yakar S, Zhao L et al (2002) Circulating insulin-like growth factor-1 levels regulate colon cancer growth and metastasis. Cancer Res 62:1030–1035

    PubMed  CAS  Google Scholar 

  • Yasumitsu T, Ohshima S, Nakano N et al (1990) Bestatin in resected lung cancer. A randomized clinical trial. Acta Oncol 29:827–831

    Article  PubMed  CAS  Google Scholar 

  • Yoshida T, Saeki T, Aoyama Y et al (1997) Treatment of head and neck cancers with BRMs — prolongation of survival. Biotherapy 10:115–120

    Article  PubMed  CAS  Google Scholar 

  • Zalcman G, Tredaniel J, Schlichtholz B et al (2000) Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer. Int J Cancer 89:81–86

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radiologische Onkologie der Universität Essen, Hufelandstrasse 55, 45122, Essen, Germany

    G. Stüben MD & M. Stuschke MD (Professor)

Authors
  1. G. Stüben MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Stuschke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, 81675, München, Germany

    Carsten Nieder MD

  2. Department of Experimental Radiation Oncology, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., P.O. Box 66, Houston, TX, 77030, USA

    Luka Milas MD, PhD

  3. Department of Radiation Oncology, UT MD Anderson Cancer Center, 1515 Holcombe Blvd., P.O. Box 66, Houston, TX, 77030, USA

    K. Kian Ang MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stüben, G., Stuschke, M. (2003). Role of Growth Factors and Biological Response Modifiers in Lung, Head and Neck and Gastrointestinal Tumors. In: Nieder, C., Milas, L., Ang, K.K. (eds) Modification of Radiation Response. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55613-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55613-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62670-8

  • Online ISBN: 978-3-642-55613-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation